Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity.
This report contains market size and forecasts of Ensartinib in global, including the following market information:
Global Ensartinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ensartinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ensartinib companies in 2021 (%)
The global Ensartinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ensartinib include BioVision, Cayman Chemical, LifeSpan BioSciences, Selleck Chemicals, AbMole, Biorbyt, LKT Laboratories, BOC Sciences and Target Molecule, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ensartinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ensartinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ensartinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Ensartinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ensartinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Ensartinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ensartinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ensartinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ensartinib revenues share in global market, 2021 (%)
Key companies Ensartinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ensartinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioVision
Cayman Chemical
LifeSpan BioSciences
Selleck Chemicals
AbMole
Biorbyt
LKT Laboratories
BOC Sciences
Target Molecule
MuseChem
Wuhan Sun-Shine Bio-Technology